All lobbying filings
Caredx, Inc.
Caredx, Inc. filed a Q3 report for Caredx, Inc. on October 13, 2026.
Lobbying for Caredx, Inc. · Clinical laboratory and transplant support services
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 13, 2026
Expenses
$30,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Lobbyists on this filing
1
-
KIMBERLY LINTHICUMPreviously held: LD, Rep. Bob Franks
Government bodies contacted
3
Lobbying activity
2
-Medicare coverage of molecular testing for solid organ allograft rejection -Medicare payment of clinical laboratory tests; implementation of Sec 216 of the Protecting Access to Medicare Act of 2014 (PL 113-93) -Prior authorization of molecular tests
Living Donor Protection Act (LDPA) S1522, HR4582,HR4583